Calamos Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $45M | Sell |
356,488
-56,102
| -14% | -$7.39M | 0.15% | 144 |
|
|
2026
Q1 | $57.5M | Buy |
412,590
+187,021
| +83% | +$26.2M | 0.2% | 110 |
|
|
2025
Q4 | $27.7M | Sell |
225,569
-9,121
| -4% | -$1.11M | 0.1% | 209 |
|
|
2025
Q3 | $26.1M | Sell |
234,690
-95
| -0% | -$10.8K | 0.1% | 228 |
|
|
2025
Q2 | $26M | Hold |
234,785
| – | – | 0.1% | 235 |
|
|
2025
Q1 | $26.3M | Buy |
234,785
+2,514
| +1% | +$259K | 0.11% | 207 |
|
|
2024
Q4 | $21.5M | Hold |
232,271
| – | – | 0.09% | 244 |
|
|
2024
Q3 | $19.5M | Sell |
232,271
-5,671
| -2% | -$433K | 0.08% | 272 |
|
|
2024
Q2 | $16.3M | Sell |
237,942
-8,703
| -4% | -$581K | 0.07% | 288 |
|
|
2024
Q1 | $18.1M | Sell |
246,645
-6,173
| -2% | -$475K | 0.09% | 269 |
|
|
2023
Q4 | $20.5M | Sell |
252,818
-4,767
| -2% | -$371K | 0.1% | 246 |
|
|
2023
Q3 | $19.3M | Sell |
257,585
-152,623
| -37% | -$11.7M | 0.1% | 247 |
|
|
2023
Q2 | $31.6M | Buy |
410,208
+113
| +0% | +$9.01K | 0.16% | 171 |
|
|
2023
Q1 | $34M | Sell |
410,095
-31,768
| -7% | -$2.63M | 0.17% | 151 |
|
|
2022
Q4 | $37.9M | Buy |
441,863
+52,186
| +13% | +$4.13M | 0.18% | 152 |
|
|
2022
Q3 | $24M | Buy |
389,677
+380
| +0.1% | +$24K | 0.11% | 220 |
|
|
2022
Q2 | $24.1M | Buy |
389,297
+9,512
| +3% | +$589K | 0.1% | 231 |
|
|
2022
Q1 | $22.6M | Buy |
379,785
+44,833
| +13% | +$2.87M | 0.08% | 260 |
|
|
2021
Q4 | $24.3M | Buy |
334,952
+11,018
| +3% | +$759K | 0.09% | 237 |
|
|
2021
Q3 | $22.6M | Buy |
323,934
+25,507
| +9% | +$1.79M | 0.1% | 229 |
|
|
2021
Q2 | $20.6M | Buy |
298,427
+56,738
| +23% | +$3.79M | 0.09% | 246 |
|
|
2021
Q1 | $15.6M | Buy |
241,689
+5,955
| +3% | +$384K | 0.09% | 251 |
|
|
2020
Q4 | $13.7M | Sell |
235,734
-8,088
| -3% | -$488K | 0.08% | 268 |
|
|
2020
Q3 | $15.4M | Sell |
243,822
-182,099
| -43% | -$12.6M | 0.1% | 224 |
|
|
2020
Q2 | $32.8M | Sell |
425,921
-116,560
| -21% | -$8.93M | 0.23% | 119 |
|
|
2020
Q1 | $40.6M | Buy |
542,481
+4,885
| +0.9% | +$338K | 0.32% | 86 |
|
|
2019
Q4 | $34.9M | Sell |
537,596
-4,346
| -0.8% | -$283K | 0.17% | 161 |
|
|
2019
Q3 | $34.3M | Buy |
541,942
+23,419
| +5% | +$1.53M | 0.19% | 163 |
|
|
2019
Q2 | $35M | Sell |
518,523
-44,661
| -8% | -$2.94M | 0.19% | 157 |
|
|
2019
Q1 | $36.6M | Buy |
563,184
+2,912
| +0.5% | +$194K | 0.23% | 139 |
|
|
2018
Q4 | $35M | Buy |
560,272
+33,331
| +6% | +$2.33M | 0.23% | 119 |
|
|
2018
Q3 | $40.7M | Buy |
526,941
+187,717
| +55% | +$14.2M | 0.22% | 119 |
|
|
2018
Q2 | $24M | Buy |
339,224
+18,191
| +6% | +$1.28M | 0.15% | 193 |
|
|
2018
Q1 | $24.2M | Buy |
321,033
+5,186
| +2% | +$412K | 0.16% | 185 |
|
|
2017
Q4 | $22.6M | Sell |
315,847
-2,987
| -0.9% | -$227K | 0.12% | 179 |
|
|
2017
Q3 | $25.8M | Buy |
318,834
+10,098
| +3% | +$772K | 0.2% | 159 |
|
|
2017
Q2 | $21.9M | Sell |
308,736
-249,599
| -45% | -$16.6M | 0.16% | 183 |
|
|
2017
Q1 | $37.9M | Sell |
558,335
-102,104
| -15% | -$7.18M | 0.3% | 95 |
|
|
2016
Q4 | $47.3M | Sell |
660,439
-6,137
| -0.9% | -$456K | 0.38% | 68 |
|
|
2016
Q3 | $52.7M | Sell |
666,576
-56,758
| -8% | -$4.61M | 0.38% | 78 |
|
|
2016
Q2 | $60.3M | Buy |
723,334
+177,612
| +33% | +$15.8M | 0.42% | 64 |
|
|
2016
Q1 | $50.1M | Buy |
545,722
+13,902
| +3% | +$1.25M | 0.33% | 91 |
|
|
2015
Q4 | $53.8M | Sell |
531,820
-20,569
| -4% | -$2.14M | 0.34% | 90 |
|
|
2015
Q3 | $54.2M | Buy |
552,389
+267
| +0% | +$29.7K | 0.37% | 78 |
|
|
2015
Q2 | $64.6M | Buy |
552,122
+155,797
| +39% | +$17M | 0.4% | 69 |
|
|
2015
Q1 | $38.9M | Sell |
396,325
-325,787
| -45% | -$33.1M | 0.24% | 127 |
|
|
2014
Q4 | $68.1M | Sell |
722,112
-210,592
| -23% | -$21.8M | 0.45% | 64 |
|
|
2014
Q3 | $99.3M | Sell |
932,704
-754,827
| -45% | -$73.9M | 0.66% | 37 |
|
|
2014
Q2 | $140M | Sell |
1,687,531
-304,119
| -15% | -$23.7M | 0.89% | 25 |
|
|
2014
Q1 | $141M | Sell |
1,991,650
-45,845
| -2% | -$3.6M | 0.9% | 25 |
|
|
2013
Q4 | $153M | Sell |
2,037,495
-261,714
| -11% | -$18.2M | 0.97% | 23 |
|
|
2013
Q3 | $144M | Sell |
2,299,209
-1,452,155
| -39% | -$86.8M | 0.91% | 28 |
|
|
2013
Q2 | $192M | Buy |
+3,751,364
| New | +$196M | 1.26% | 18 |
|
Other funds holding GILD
Calamos Advisors's GILD Position: Q2 2026 in Review
Calamos Advisors reduced its Gilead Sciences (GILD) stake by 14% in Q2 2026, selling an estimated $7.39M and leaving 356,488 shares worth $45M. The position accounts for 0.15% of the portfolio, ranked #144.
Calamos Advisors first reported a position in GILD in Q2 2013 and has held it in 53 quarters since. The position peaked at $192M in Q2 2013. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Calamos Advisors held 356,488 shares of Gilead Sciences worth $45M as of Q2 2026.
- Calamos Advisors sold 56,102 Gilead Sciences shares in Q2 2026, an estimated $7.39M.
- Gilead Sciences made up 0.15% of Calamos Advisors's portfolio in Q2 2026, its #144 holding.
- Calamos Advisors first reported a position in Gilead Sciences in Q2 2013 and has held it in 53 quarters since.
- Calamos Advisors's Gilead Sciences position peaked at $192M in Q2 2013.
- 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Calamos Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.